DMD transcript imbalance determines dystrophin levels
The DOI matches its Crossref record.
Abstract
Duchenne and Becker muscular dystrophies are caused by out‐of‐frame and in‐frame mutations, respectively, in the dystrophin encoding DMD gene. Molecular therapies targeting the precursormRNA are in clinical trials and show promising results. These approaches will depend on the stability and expression levels of dystrophin mRNA in skeletal muscles and heart. We report that the DMD gene is more highly expressed in heart than in skeletal muscles, in mice and humans. The transcript mutated in the mdx mouse model shows a 5′ to 3′ imbalance compared with that of its wild‐type counterpart and reading frame restoration via antisense‐mediated exon skipping does not correct this event. We also report significant transcript instability in 22 patients with Becker dystrophy, clarifying the fact that transcript imbalance is not caused by premature nonsense mutations. Finally, we demonstrate that transcript stability, rather than transcriptional rate, is an important determinant of dystrophin protein levels in patients with Becker dystrophy. We suggest that the availability of the complete transcript is a key factor to determine protein abundance and thus will influence the outcome of mRNA‐targeting therapies.—Spitali, P., van den Bergen, J. D., Verhaart, I. E. C., Wokke, B., Janson, A.A.M., van den Eijnde, R., den Dunnen, J. T., Laros, J. F. J., Verschuuren, J. G. M., 't Hoen, P. A. C., Aartsma‐Rus, A., DMD transcript imbalance determines dystrophin levels. FASEB J. 27, 4909–4916 (2013). www.fasebj.org
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This discrepancy could result from differences in transcript processing dynamics between mice and humans (Gazzoli et al., 2016; Spitali et al., 2013).”
From Understanding Duchenne muscular dystrophy-associated brain pathology (2025) · cites this paper as Spitali et al., 2013
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 27
- 10.1093/brain/awp236 · DOI · Paper page
- 10.1002/humu.20976 · DOI · Paper page
- 10.1016/j.nmd.2010.03.007 · DOI
- 10.1056/NEJM198805263182104 · DOI · Paper page
- 10.1016/S1474-4422(03)00585-4 · DOI · Paper page
- 10.1016/0092-8674(90)90419-F · DOI · Paper page
- 10.1083/jcb.151.6.1321 · DOI · Paper page
- 10.1186/1471-2105-3-4 · DOI · Paper page
- 10.1016/S0960-8966(02)00093-7 · DOI · Paper page
- 10.1073/pnas.192571199 · DOI · Paper page
- 10.1007/s10048-003-0148-x · doi:10.1007/s10048-003-0148-x
- 10.1096/fj.06-7285com · DOI · Paper page
- 10.1002/humu.22017 · doi:10.1002/humu.22017
- 10.1002/ajmg.b.30234 · DOI
- 10.1093/nar/24.15.3059 · DOI
- 10.1038/ng0295-184 · DOI · Paper page
- 10.1002/humu.20918 · DOI · Paper page
- 10.1038/nature05756 · DOI · Paper page
- 10.1056/NEJMoa1011367 · DOI · Paper page
- 10.1177/0883073810371129 · DOI · Paper page
- 10.1016/j.nmd.2010.02.004 · DOI
- 10.1038/labinvest.2010.98 · doi:10.1038/labinvest.2010.98
- 10.1111/j.1749-6632.2009.04973.x · DOI
- Verhaart I. E., 2012, The effect of 6‐thioguanine on alternative splicing and antisense‐mediated exon skipping treatment for duchenne muscular dystrophy, PLoS Curr., 4
- 10.1111/j.1399-0004.2005.00455.x · doi:10.1111/j.1399-0004.2005.00455.x
- 10.1038/sj.gt.3302313 · DOI
- 10.1089/hum.2006.061 · DOI
Cited by
Understanding Duchenne muscular dystrophy-associated brain pathology
Verhaeg, M. A. T., Govaarts, R., & van Putten, M. (2025) · Disease Models & Mechanisms · doi:10.1242/dmm.052302 · Cited by 5
Metadata
- Authors
- Spitali, P., van den Bergen, J. C., Verhaart, I. E. C., Wokke, B., Janson, A. A. M., van den Eijnde, R., den Dunnen, J. T., Laros, J. F. J., Verschuuren, J. J. G. M., Hoen, P. A. C. '., & Aartsma‐Rus, A.
- Affiliations
- Department of Human Genetics Leiden University Medical Center Leiden The Netherlands
- Department of Neurology Leiden University Medical Center Leiden The Netherlands
- Prosensa Therapeutics Leiden The Netherlands
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2013-08-23
- Volume
- 27
- Issue
- 12
- Pages
- 4909-4916
- ISSN
- 0892-6638
- 1530-6860
- Cited by
- 49
- References
- 0
- Language
- en
- Funders
- ZonMw
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.